Abstract
The correction of a bleeding defect.- Report on a tissue extract: Clauden(R).- Report on a preparation of phospholipids: Tachostyptan(R).- Comments by the manufacturer of Tachostyptan(R).- Report on a preparation of oxalic acid and malonic acid: Koagamin(R).- Report on a preparation of butyl alcohol: Haemostypticum Revici(R).- Report on sodium 4-aminonaphthalene-l-sulphonate: Naphthionin(R).- Report on ethamsylate.- Comments by the manufacturer of Dicynene(R).- Report on aminaphtone.- Comments by the manufacturer of Capillarema(R).- Report on a preparation of pectin: Sangostop(R).- Report on naftazone.- Comments by the manufacturer of Karbinone(R).- Report on adrenochrome monosemicarbazide and carbazochrome salicylate.- Comments on adrenochrome.- Report on 5-hydroxytryptamine creatinine sulphate: Antemovis(R).- Report on a preparation of conjugated oestrogens: Premarin(R).- Comments by the manufacturer of Premarin(R).- Report on a preparation of oestriol succinate: Styptanon(R).- Comments by the manufacturer of Styptanon(R).- Report on a preparation of snake venom: Botropase(R).- Comments on Botropase(R).- Report on a preparation of snake venom: Reptilase(R).- Comments by the manufacturer of Reptilase(R).- Report on aprotinin: Trasylol(R).- Report on epsilon aminocaproic acid.- Report on p-aminomethyl-benzoic acid.- Report on tranexamic acid..- Comments by the manufacturer of Cyklokapron(R).- Haemostatic agents for topical use.- A note on vitamin C and bioflavonoids.- Recommendations for clinical trials with systemic haemostatic agents.- Conclusions on the clinical efficacy of general haemostatic drugs.- List of haemostatic drugs mentioned in the text.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
